Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Iva Ugrinova is active.

Publication


Featured researches published by Iva Ugrinova.


Molecular and Cellular Biochemistry | 2010

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

Nora Kostova; Stanislava Zlateva; Iva Ugrinova; Evdokia Pasheva

High Mobility Group Box 1 (HMGB1) is a nuclear non-histone protein discovered to be released in the extracellular medium as a response to various stimuli and implicated in cancerogenesis. High HMGB1 levels are reported in a variety of tumor types, but there are few data relating HMGB1 to the histological grade or to a particular cell type and cellular localization. We studied the expression of HMGB1 protein in malignant human tumors of different differentiation level and in tumor metastasis. In all tumor tissues, the protein level is elevated. In moderately differentiated carcinomas, the localization of the protein is perinuclear, while in the low differentiated; there is a tendency for non-specific nuclear localization. HMGB1 protein and its receptor RAGE are identified as a ligand–receptor pair that plays an important role in regulating the invasiveness of tumor cells. RAGE is not produced in all of the tested tumor specimens. We found high level of expression in hepatocellular, colorectal, and breast cribriform carcinomas, but not in malignant testicular specimens. Probably, the RAGE synthesis is related to distinctive tumor types. In metastatic cells, RAGE exhibits higher level of expression losing its specific granular cytosolic pattern characteristic for the primary tumors.


Bioorganic & Medicinal Chemistry | 2013

A novel pH sensitive water soluble fluorescent nanomicellar sensor for potential biomedical applications

Nikolai I. Georgiev; Rayna Bryaskova; Rumiana Tzoneva; Iva Ugrinova; Christophe Detrembleur; Stoyan Miloshev; Abdullah M. Asiri; Abdullah H. Qusti; Vladimir B. Bojinov

Herein we report on the synthesis and sensor activity of a novel pH sensitive probe designed as highly water-soluble fluorescent micelles by grafting of 1,8-naphthalimide-rhodamine bichromophoric FRET system (RNI) to the PMMA block of a well-defined amphiphilic diblock copolymer-poly(methyl methacrylate)-b-poly(methacrylic acid) (PMMA48-b-PMAA27). The RNI-PMMA48-b-PMAA27 adduct is capable of self-assembling into micelles with a hydrophobic PMMA core, containing the anchored fluorescent probe, and a hydrophilic shell composed of PMAA block. Novel fluorescent micelles are able to serve as a highly sensitive pH probe in water and to internalize successfully HeLa and HEK cells. Furthermore, they showed cell specificity and significantly higher photostability than that of a pure organic dye label such as BODIPY. The valuable properties of the newly prepared fluorescent micelles indicate the high potential of the probe for future biological and biomedical applications.


The International Journal of Biochemistry & Cell Biology | 2008

HMGB1 protein inhibits DNA replication in vitro: A role of the acetylation and the acidic tail

Dessislava Topalova; Iva Ugrinova; Iliya G. Pashev; Evdokia Pasheva

The high mobility group box (HMGB) 1 protein is a very abundant and conserved protein that is implicated in many key cellular events but its functions within the nucleus remain elusive. The role of this protein in replication of closed circular DNA containing a eukaryotic origin of replication has been studied in vitro by using native and recombinant HMGB1 as well as various modified HMGB1 preparations such as truncated protein, lacking its C-terminal tail, in vivo acetylated protein, and recombinant HMGB1 phosphorylated in vitro by protein kinase C (PKC). Native HMGB1 extracted from tumour cells inhibits replication and this effect is reduced upon acetylation and completely abolished upon removal of the acidic C-terminal tail. Recombinant HMGB1, however, fails to inhibit replication but it acquires such a property following in vitro phosphorylation by PKC.


Biochemistry | 2009

Nucleosome Binding Properties and Co-Remodeling Activities of Native and in Vivo Acetylated HMGB-1 and HMGB-2 Proteins †

Iva Ugrinova; Iliya G. Pashev; Evdokia Pasheva

The participation of HMGB-1 and -2 proteins in chromatin remodeling is investigated. Here, the ability of these proteins and their posttranslationally acetylated forms to affect SWI/SNF and RSC-dependent nucleosome mobilization was studied. Both proteins assisted nucleosome sliding induced by the two remodelers. Following acetylation, these proteins acquire the ability to bind to core particles, a property that has not yet been documented with parental proteins. We further report that compared to the nonmodified proteins, acetylated HMGB-1 and -2 exhibited both stronger binding to linker DNA-containing nucleosomes and a higher co-remodeling activity. Acetylation of HMGB-1 and -2 proteins enhanced binding of SWI/SNF to the nucleosome but did not affect its ATPase activity.


The International Journal of Biochemistry & Cell Biology | 2009

Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro.

Iva Ugrinova; Stanislava Zlateva; Iliya G. Pashev; Evdokia Pasheva

The high mobility group box (HMGB) 1 protein, one of the most abundant nuclear non-histone proteins has been known for its inhibitory effect on repair of DNA damaged by the antitumor drug cisplatin. Here, we report the first results that link HMGB1 to repair of cisplatin-treated DNA at nucleosome level. Experiments were carried out with three types of reconstituted nucleosomes strongly positioned on the damaged DNA: linker DNA containing nucleosomes (centrally and end-positioned) and core particles. The highest repair synthesis was registered with end-positioned nucleosomes, two and three times more efficient than that with centrally positioned nucleosomes and core particles, respectively. HMGB1 inhibited repair of linker DNA containing nucleosomes more efficiently than that of core particles. Just the opposite was the effect of the in vivo acetylated HMGB1: stronger repair inhibition was obtained with core particles. No inhibition was observed with HMGB1 lacking the acidic tail. Binding of HMGB1 proteins to different nucleosomes was also analysed. HMGB1 bound preferentially to damage nucleosomes containing linker DNA, while the binding of the acetylated protein was linker independent. We show that both the repair of cisplatin-damaged nucleosomes and its inhibition by HMGB1 are nucleosome position-dependent events which are accomplished via the acidic tail and modulated by acetylation.


The International Journal of Biochemistry & Cell Biology | 2002

The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity

Evdokia Pasheva; Iva Ugrinova; Nadejda Spassovska; Iliya G. Pashev

The antitumor activity of cis-platin is believed to result from its interaction with cellular DNA and subsequent processing of DNA adducts by damage recognition proteins. Among them are the high mobility group (HMG) proteins 1 and 2, which have been hypothesized to mediate the effect of cis-platin. One possibility suggests that the tight binding of HMG1 to DNA adducts blocks the repair of damaged DNA. In order to further evaluate such a mechanism, several cis-platinum complexes with known antitumor activity have been used to treat DNA and the affinity of HMG1 to the DNA adduct induced by each drug was determined. The dissociation constants for the complexes of HMG1 with the platinated probe were obtained by gel mobility shift assays. The antitumor activity of the tested platinum compounds was found to correlate with the binding affinity of HMG1 to the respective drug-DNA adduct. These findings support the view that HMG1 contributes to cytotoxicity of cis-platin by shielding damaged DNA from repair. In addition, they offer a fast test for screening new platinum compounds for antitumor activity.


Molecular Biology Reports | 2009

Post-synthetic acetylation of HMGB1 protein modulates its interactions with supercoiled DNA

Iva Ugrinova; Iliya G. Pashev; Evdokia Pasheva

High mobility group box (HMGB) proteins 1 and 2 are abundant non-histone nuclear proteins that regulate chromatin structure because of their structure-specific binding to DNA. Here, we have investigated how the post-synthetic acetylation of HMGB1 affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from butyrate-treated cells. Our data reveal that this modification enhances three reaction parameters: binding affinity, supercoiling activity and capacity to protect the supercoiled DNA from relaxation by topoisomerase I. We show that monoacetylation at Lys2 mimics the effect of acidic tail removal but to a lesser extent thus demonstrating that in vivo acetylated HMGB1 is capable of modulating its interaction with negatively supercoiled DNA.


Investigational New Drugs | 2011

In vitro pharmacological study of monomeric platinum(III) hematoporphyrin IX complexes

Georgi Momekov; Margarita Karaivanova; Iva Ugrinova; Evdokia Pasheva; G. Gencheva; Daniela Tsekova; Sonia Arpadjan; P.R. Bontchev

SummaryThree stable mononuclear hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) complexes of PtIII, namely cis-[ PtIII(NH3)2(Hp−3H)(H2O)2].H2O 1, [PtIII(Hp−3H)(H2O)2].H2O 2 and [PtIII((O,O)Hp−2H)Cl(H2O)3] 3 with distorted octahedral structure and (dz2)1 ground state have been tested in vitro for antineoplastic activity in a panel of tumor cell lines. The novel platinum(III) complexes showed cytotoxic activity in a concentration-dependent manner with IC50 values comparable to those of referent cytotoxic agent cisplatin together with lower cytotoxicity against renal cells. Further detailed evaluation of the active analogue 2 and the less active complex 3 showed that their potency greatly correlates with the ability to induce apoptosis and to bind DNA. Despite the structural dissimilarities between complex 2 and cisplatin, their DNA-adducts were equally effectively recognized and repaired by the nucleotide excision repair system. Complex 2 showed quite superior ability to accumulate in K-562 cells relative to cisplatin.


Cell Cycle | 2015

Centrosomal nucleolin is required for microtubule network organization

Xavier Gaume; Anne-Marie Tassin; Iva Ugrinova; Fabien Mongelard; Karine Monier; Philippe Bouvet

Nucleolin is a pleiotropic protein involved in a variety of cellular processes. Although multipolar spindle formation has been observed after nucleolin depletion, the roles of nucleolin in centrosome regulation and functions have not been addressed. Here we report using immunofluorescence and biochemically purified centrosomes that nucleolin co-localized only with one of the centrioles during interphase which was further identified as the mature centriole. Upon nucleolin depletion, cells exhibited an amplification of immature centriole markers surrounded by irregular pericentrin staining; these structures were exempt from maturation markers and unable to nucleate microtubules. Furthermore, the microtubule network was disorganized in these cells, exhibiting frequent non-centrosomal microtubules. At the mature centriole a reduced kinetics in the centrosomal microtubule nucleation phase was observed in live silenced cells, as well as a perturbation of microtubule anchoring. Immunoprecipitation experiments showed that nucleolin belongs to protein complexes containing 2 key centrosomal proteins, γ-tubulin and ninein, involved in microtubule nucleation and anchoring steps. Altogether, our study uncovered a new role for nucleolin in restricting microtubule nucleation and anchoring at centrosomes in interphase cells.


European Journal of Medicinal Chemistry | 2014

Enantiopure antituberculosis candidates synthesized from (-)-fenchone.

Georgi M. Dobrikov; Violeta Valcheva; Yana Nikolova; Iva Ugrinova; Evdokia Pasheva; Vladimir Dimitrov

The synthesis of new enantiopure N-acyl compounds derived from (-)-fenchone has been performed. The evaluation of their in vitro activity against Mycobacterium tuberculosis H37Rv showed for most of them moderate activity. The structures bearing sulfonamide functionality have comparable activity to ethambutol and possess low cytotoxicity.

Collaboration


Dive into the Iva Ugrinova's collaboration.

Top Co-Authors

Avatar

Evdokia Pasheva

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Iliya G. Pashev

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Georgi M. Dobrikov

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Stanislava Zlateva

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Vladimir Dimitrov

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Violeta Valcheva

Bulgarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Philippe Bouvet

École normale supérieure de Lyon

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge